Header Logo

Connection

Doris Benbrook to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Doris Benbrook has written about Drug Administration Schedule.
Doris Benbrook
Connection Strength
0.100
Drug Administration Schedule
  1. A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Nov; 127(2):356-61.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.